Lc3Cer-合成B3GNT5によるEMT-METと化学抵抗の調節
Laura E Clark1, Katherine Hylton Rorie1, Amanda J G Dickinson1
1Department of Biology, Virginia Commonwealth University, Richmond, VA, 23284, USA.
BMC cancer
|August 23, 2025
まとめ
B3GNT5遺伝子はガンの悪性腫瘍に不可欠なグリコスフィンゴリピド (GSL) を調節する. B3GNT5を潜在的治療標的として示唆する.
科学分野:
- 生物化学
- 癌 生物学
- 分子腫瘍学
背景:
- グライコスフィンゴリピッド (GSL) は,化学抵抗,上皮-メゼンキマトランジション (EMT),受容体チロシンキナーゼ (RTK) の活性化を含む,悪性腫瘍に影響を与える重要な血成分です.
- B3GNT5はGSLのバイオシンセシスの重要なレギュラーであり,ラクトシドおよびネオラクトシドGSLシリーズの前駆体を生成する.
研究 の 目的:
- B3GNT5の悪性腫瘍における役割を調査する.
- B3GNT5の変異と発現が癌の進行と患者のアウトカムに与える影響を評価する.
主な方法:
- B3GNT5の病変と発現に関する公開されているがんゲノムデータの分析.
- CRISPR- Cas9は,HeLa細胞におけるB3GNT5の部分的な枯渇を媒介し,フェノタイプの変化を評価した.
- B3GNT5レベルに影響を受けたGSL前体 (GlcCer,LacCer) を定量化するための質量スペクトロメトリ.
主要な成果:
- B3GNT5の複製数増加と過剰発現はヒトの癌で多く見られ,予後が悪いと相関しています.
- HeLa細胞におけるB3GNT5の部分的な枯渇は,GlcCerとLacCerの蓄積,化学抵抗性の増加,EMTマーカーの変化,RTKの活性化の減少をもたらした.
- これらの発見は,B3GNT5がGSL代謝,シグナル伝達経路,悪性現象に影響することを示している.
結論:
- B3GNT5の変異は,がんにおいて頻繁に見られ,有害な結果と関連しています.
- B3GNT5は,GSLの代謝,がんのシグナル伝達,悪性現象において重要な役割を果たします.
- B3GNT5はがん治療において有望な治療目標である.
さらに関連する動画
06:58Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
807
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.9K
関連する概念動画
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
